These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22427881)

  • 1. Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection.
    Huang XY; Shi GM; Devbhandari RP; Ke AW; Wang Y; Wang XY; Wang Z; Shi YH; Xiao YS; Ding ZB; Dai Z; Xu Y; Jia WP; Tang ZY; Fan J; Zhou J
    PLoS One; 2012; 7(3):e32775. PubMed ID: 22427881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.
    Song H; Li Y; Lee J; Schwartz AL; Bu G
    Cancer Res; 2009 Feb; 69(3):879-86. PubMed ID: 19176371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.
    Kim HJ; Moon JH; Kim HM; Yun MR; Jeon BH; Lee B; Kang ES; Lee HC; Cha BS
    Metabolism; 2014 Jan; 63(1):112-9. PubMed ID: 24139096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of XRCC5 is associated with metastasis through Wnt signaling pathway and predicts poor prognosis in patients with hepatocellular carcinoma.
    Liu ZH; Wang N; Wang FQ; Dong Q; Ding J
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7835-7847. PubMed ID: 31599408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of long noncoding RNA linc00261 in hepatocellular carcinoma and its association with postoperative outcomes].
    Chen Z; Xiang L; Huang Y; Fang Y; Li X; Yang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1179-1186. PubMed ID: 30377132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma.
    Ye L; Kriegl L; Reiter FP; Munker SM; Itzel T; Teufel A; Ziesch A; Török HP; Kirchner T; Gerbes AL; Guba M; Mayerle J; De Toni EN
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00124. PubMed ID: 31990698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC.
    Yi Y; Wu H; Gao Q; He HW; Li YW; Cai XY; Wang JX; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    Ann Surg Oncol; 2013 Jan; 20(1):267-76. PubMed ID: 22805863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.
    Gao YB; Xiang ZL; Zhou LY; Wu ZF; Fan J; Zeng HY; Zeng ZC
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):669-79. PubMed ID: 23307318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
    Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ruan J; Zheng H; Rong X; Rong X; Zhang J; Fang W; Zhao P; Luo R
    Mol Cancer; 2016 Feb; 15():17. PubMed ID: 26896959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
    Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
    Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity.
    Dou CY; Cao CJ; Wang Z; Zhang RH; Huang LL; Lian JY; Xie WL; Wang LT
    Oncol Rep; 2016 Jun; 35(6):3489-95. PubMed ID: 27108677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.